Illumina, Inc. (NASDAQ:ILMN) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Illumina, Inc.

Plants produce a wide diversity of compounds. Broadly, these are separated into primary metabolites, which are necessary for ...

From the time we are conceived and through old age, genetic mutations accumulate in all our tissues, eluding the body's ...

In recent years, Novogene Europe has systematically integrated state-of-the-art technologies across its service portfolio, ...

The global Metagenomics Market is estimated to be valued at USD 231.1 million in 2025 and is projected to reach USD 442.07 million by 2035, registering a CAGR of 6.7% over the forecast period. The ...

Illumina’s first quarter results reflected ongoing challenges in the global genomics market, as the company’s performance ...

The Global Bioinformatics Market is expected to grow at a rate of 13-14% by 2029. The rising government initiatives and ...

Imagine that you want to know the plot of a movie, but you only have access to either the visuals or the sound. With visuals ...

Market Growth Driven by Declining Sequencing Costs, Rising Prevalence of Genetic Disorders, Expanding Clinical Applications, and Technologica ...

According to a comprehensive market research report titled "Metagenomics Market Size, Share, Forecast, & Trends Analysis by ...